Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Over the last 12 months, insiders at Thermo Fisher Scientific Inc. have bought $2,105 and sold $170.78M worth of Thermo Fisher Scientific Inc. stock.
On average, over the past 5 years, insiders at Thermo Fisher Scientific Inc. have bought $2,105 and sold $180.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Boxer Michael A (SVP and General Counsel) — $2,105.
The last purchase of 4 shares for transaction amount of $2,105 was made by Boxer Michael A (SVP and General Counsel) on 2023‑06‑26.
2024-06-04 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $570.16 | $5.7M | +0.44% | |
2024-06-03 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $567.28 | $5.67M | +0.43% | |
2024-05-14 | Sale | Lagarde Michel | Executive Vice President & COO | 20,000 0.0052% | $590.05 | $11.8M | -3.51% | |
2024-05-13 | Sale | Williamson Stephen | Sr. VP and CFO | 21,925 0.0057% | $591.27 | $12.96M | -2.63% | |
2024-05-01 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $573.74 | $5.74M | -0.25% | |
2024-04-30 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $572.41 | $5.72M | +0.98% | |
2024-04-29 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $575.94 | $5.76M | -0.58% | |
2024-04-26 | Sale | Boxer Michael A | SVP and General Counsel | 2,000 0.0005% | $567.94 | $1.14M | +0.12% | |
2024-03-13 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $594.58 | $5.95M | -3.09% | |
2024-03-12 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $597.98 | $5.98M | -3.72% | |
2024-03-12 | Sale | Britt Lisa P. | Sr. VP and Chief HR Officer | 5,900 0.0015% | $598.90 | $3.53M | -3.72% | |
2024-03-11 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $595.36 | $5.95M | -4.11% | |
2024-02-29 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $571.08 | $5.71M | +1.04% | |
2024-02-28 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $570.18 | $5.7M | +0.67% | |
2024-02-27 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0026% | $564.72 | $5.65M | +1.70% | |
2024-02-15 | Sale | CASPER MARC N | Chairman & CEO | 5,547 0.0014% | $550.62 | $3.05M | +4.82% | |
2024-02-12 | Sale | Spar Debora L | director | 164 <0.0001% | $546.97 | $89,703 | +4.99% | |
2024-02-07 | Sale | CASPER MARC N | Chairman & CEO | 10,000 0.0025% | $555.63 | $5.56M | +3.85% | |
2024-02-07 | Sale | Boxer Michael A | SVP and General Counsel | 14,566 0.0037% | $562.00 | $8.19M | +3.85% | |
2023-11-07 | Sale | CASPER MARC N | Chairman & CEO | 1,600 0.0004% | $460.25 | $736,404 | +22.06% |
CASPER MARC N | Chairman & CEO | 123816 0.0127% | $558.17 | 1 | 133 | +23.49% |
Williamson Stephen | Sr. VP and CFO | 36482 0.0071% | $558.17 | 0 | 20 | |
Britt Lisa P. | Sr. VP and Chief HR Officer | 17323 0.0045% | $558.17 | 0 | 1 | |
Pettiti Gianluca | Executive Vice President | 17556 0.0045% | $558.17 | 0 | 3 | |
Lagarde Michel | Executive Vice President & COO | 18134 0.0041% | $558.17 | 0 | 9 | |
Boxer Michael A | SVP and General Counsel | 13083 0.0033% | $558.17 | 1 | 3 | |
Spar Debora L | director | 1207 0.0003% | $558.17 | 0 | 3 | |
MEISTER PAUL M | director | 350000 0.0906% | $558.17 | 0 | 10 | |
MELAS KYRIAZI THEO | VP & Chief Financial Officer | 131079 0.0339% | $558.17 | 0 | 3 | |
DEKKERS MARIJN E | Chief Executive Officer | 91878 0.0238% | $558.17 | 0 | 18 | |
Pesicka Edward A | Senior Vice President | 80641 0.0209% | $558.17 | 0 | 16 | |
SPERLING SCOTT M | director | 80440 0.0208% | $558.17 | 1 | 4 | +21.2% |
SYRON RICHARD F/CA | Executive Chairman | 80320 0.0208% | $558.17 | 0 | 7 | |
WILVER PETER M | Exec. VP & Chief Admin Officer | 62517 0.0162% | $558.17 | 0 | 19 | |
Stevenson Mark | Executive Vice President & COO | 59256 0.0153% | $558.17 | 0 | 12 | |
Thomson Andrew J | Senior Vice President | 55614 0.0144% | $558.17 | 0 | 6 | |
Malus Alan J | Executive Vice President | 47286 0.0122% | $558.17 | 0 | 34 | |
Loewald Thomas W | Senior Vice President | 41277 0.0107% | $558.17 | 0 | 19 | |
Berger Kenneth | Senior Vice President | 38314 0.0099% | $558.17 | 0 | 7 | |
Durbin Patrick M | Senior Vice President | 34177 0.0088% | $558.17 | 0 | 3 | |
Herrema Gregory J. | Senior Vice President | 29459 0.0076% | $558.17 | 1 | 8 | +20.78% |
HOOGASIAN SETH H | Sr. VP and Gen. Counsel | 25518 0.0066% | $558.17 | 0 | 39 | |
BROADBENT GUY | Senior Vice President | 24655 0.0064% | $558.17 | 0 | 18 | |
HOWE BARRY S | VP, Measurement & Control | 23247 0.006% | $558.17 | 0 | 1 | |
Jafry Syed A. | Sr. Vice President | 21019 0.0054% | $558.17 | 0 | 1 | |
Shine Daniel P | Senior Vice President | 20682 0.0054% | $558.17 | 0 | 9 | |
HORNSTRA PETER E | VP & Chief Accounting Officer | 18212 0.0047% | $558.17 | 0 | 21 | |
Massaro Joseph R | Sr. VP, Global Bus. Services | 15000 0.0039% | $558.17 | 0 | 4 | |
MANZI JIM P | director | 14807 0.0038% | $558.17 | 0 | 24 | |
PORTER MICHAEL E | director | 14640 0.0038% | $558.17 | 2 | 13 | +13.17% |
Walder Fredric T | Sr. VP, Customer Excellence | 14230 0.0037% | $558.17 | 0 | 2 | |
LEWENT JUDY C | director | 12188 0.0032% | $558.17 | 0 | 1 | |
Parrett William G | director | 11660 0.003% | $558.17 | 2 | 3 | +8.49% |
LYNCH THOMAS J | director | 11096 0.0029% | $558.17 | 0 | 3 | |
ULLIAN ELAINE | director | 10109 0.0026% | $558.17 | 1 | 8 | <0.0001% |
HARRIS C MARTIN | director | 6358 0.0016% | $558.17 | 0 | 7 | |
KOEPFGEN BRUCE L | director | 6143 0.0016% | $558.17 | 0 | 1 | |
Jacks Tyler | director | 5879 0.0015% | $558.17 | 1 | 4 | +3.97% |
SHEEHAN STEPHEN G | Sr. VP, Human Resources | 5618 0.0015% | $558.17 | 0 | 6 | |
MANNING PETER J | director | 4600 0.0012% | $558.17 | 5 | 4 | +15.57% |
KAUFMAN STEPHEN P | director | 1000 0.0003% | $558.17 | 1 | 0 | +6.6% |
Holmes Joseph R. | VP & Chief Accounting Officer | 897 0.0002% | $558.17 | 0 | 1 | |
O LEARY ROBERT | director | 0 0% | $558.17 | 0 | 1 | |
Bell Michael Adam | director | 173 0% | $558.17 | 1 | 0 | +8.84% |
The Vanguard Group | $19.24B | 8.67 | 33.1M | +0.36% | +$68.21M | 0.37 | |
BlackRock | $16.84B | 7.59 | 28.98M | +2.29% | +$377.81M | 0.38 | |
State Street | $9.65B | 4.35 | 16.58M | +0.65% | +$62.27M | 0.42 | |
Capital World Investors | $7.84B | 3.54 | 13.49M | +10.04% | +$715.5M | 1.3 | |
Morgan Stanley | $6.83B | 3.08 | 11.75M | -6.37% | -$464.74M | 0.53 | |
T. Rowe Price | $5.84B | 2.63 | 10.05M | +1.58% | +$91.06M | 0.72 | |
Capital Research Global Investors | $4.72B | 2.13 | 8.11M | +1.55% | +$71.79M | 1.07 | |
Geode Capital Management | $4.34B | 1.96 | 7.5M | +2.79% | +$117.8M | 0.39 | |
Fidelity Investments | $4.02B | 1.81 | 6.92M | -11.87% | -$541.44M | 0.27 | |
Bank of America | $2.96B | 1.33 | 5.09M | +3.77% | +$107.38M | 0.29 | |
JPMorgan Chase | $2.57B | 1.16 | 4.42M | +17.04% | +$373.94M | 0.23 | |
Massachusetts Financial Services Co Ma | $2.5B | 1.13 | 4.31M | +3.04% | +$73.73M | 0.75 | |
Franklin Templeton Investments | $2.38B | 1.07 | 4.09M | +62.47% | +$914.48M | 0.72 | |
Northern Trust | $2.13B | 0.96 | 3.67M | -3.16% | -$69.52M | 0.36 | |
Polen Capital | $1.89B | 0.85 | 3.26M | +60.29% | +$712.45M | 4.38 | |
Royal Bank of Canada | $1.87B | 0.84 | 3.21M | -0.94% | -$17.82M | 0.45 | |
Wellington Management Company | $1.78B | 0.8 | 3.07M | +2.76% | +$47.88M | 0.3 | |
Legal & General | $1.77B | 0.8 | 3.04M | -2.64% | -$47.86M | 0.41 | |
BNY Mellon | $1.63B | 0.73 | 2.8M | -5.39% | -$92.72M | 0.31 | |
PRIMECAP Management Co | $1.6B | 0.72 | 2.76M | -8.17% | -$142.58M | 1.21 | |
Fisher Asset Management Llc | $1.45B | 0.65 | 2.5M | -2.89% | -$43.17M | 0.68 | |
Charles Schwab | $1.36B | 0.62 | 2.35M | +3.12% | +$41.35M | 0.31 | |
UBS | $1.33B | 0.6 | 2.29M | +9.14% | +$111.52M | 0.4 | |
ClearBridge Investments | $1.3B | 0.59 | 2.24M | +0.36% | +$4.68M | 1.04 | |
Amundi | $1.2B | 0.58 | 2.2M | -11.54% | -$156.37M | 0.5 | |
Dz Bank Ag Deutsche Zentral Genossenschafts Bank Frankfurt Am Main | $1.27B | 0.57 | 2.19M | +33.13% | +$316.14M | 1.44 | |
The Manufacturers Life Insurance Company | $1.15B | 0.52 | 1.98M | -15.8% | -$215.83M | 1.04 | |
Goldman Sachs | $1.14B | 0.51 | 1.96M | +0.64% | +$7.18M | 0.22 | |
Ameriprise Financial | $1.09B | 0.49 | 1.88M | +35.67% | +$286.73M | 0.3 | |
AllianceBernstein | $1.08B | 0.49 | 1.85M | +1.05% | +$11.2M | 0.38 | |
LAZARD ASSET MANAGEMENT LLC | $1.07B | 0.48 | 1.84M | -1.98% | -$21.65M | 1.41 | |
Dimensional Fund Advisors | $999.92M | 0.45 | 1.72M | +0.6% | +$5.95M | 0.27 | |
Brown Advisory | $985.9M | 0.44 | 1.7M | -10.45% | -$115.08M | 1.32 | |
Veritas Asset Management LLP | $982.38M | 0.44 | 1.69M | -0.11% | -$1.11M | 7.13 | |
Generation Investment Management Llp | $962.16M | 0.43 | 1.66M | -7.06% | -$73.12M | 4.39 | |
Ubs Asset Management Americas Inc | $920.45M | 0.42 | 1.58M | -1.73% | -$16.16M | 0.33 | |
Barclays | $884.3M | 0.4 | 1.52M | -0.77% | -$6.86M | 0.4 | |
TCI FUND MANAGEMENT LIMITED | $882.07M | 0.4 | 1.52M | -51.77% | -$946.64M | 2.22 | |
Wells Fargo | $881.86M | 0.4 | 1.52M | +0.22% | +$1.93M | 0.24 | |
Mitsubishi UFJ Kokusai Asset Management | $866.98M | 0.39 | 1.49M | -16.39% | -$169.99M | 1.2 | |
Schroder Investment Management Group | $857.46M | 0.39 | 1.48M | +13.01% | +$98.73M | 1.02 | |
Parnassus Investments Ca | $797.56M | 0.36 | 1.37M | -1.01% | -$8.16M | 1.71 | |
Flossbach von Storch | $778.42M | 0.35 | 1.34M | -1.14% | -$8.97M | 3.4 | |
Invesco | $774.29M | 0.35 | 1.33M | -20.41% | -$198.62M | 0.16 | |
Janus Henderson | $768.95M | 0.35 | 1.32M | -1.82% | -$14.28M | 0.42 | |
Nuveen | $733.96M | 0.33 | 1.26M | -0.36% | -$2.68M | 0.22 | |
Voya Investment Management LLC | $727.93M | 0.33 | 1.25M | -26.02% | -$256.01M | 0.82 | |
Ensign Peak Advisors Inc | $708.88M | 0.32 | 1.22M | +12.22% | +$77.17M | 1.25 | |
Deutsche Bank | $708.36M | 0.32 | 1.22M | -7.29% | -$55.73M | 0.32 | |
C Worldwide Group Holding A S | $689.93M | 0.31 | 1.19M | -0.65% | -$4.53M | 7.86 |